☆ 4.7 Review

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz et al.

Summary: The study suggests a positive selection for the SARS-CoV-2 spike protein variant D614G in the UK, but no evidence of differences in COVID-19 mortality or clinical severity in patients infected with this variant. 614G is associated with higher viral load and younger age of patients compared to 614D.

CELL (2021)

Add to Collection

Article Infectious Diseases

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Kathy Leung et al.

Summary: Two new lineages of SARS-CoV-2 with the N501Y mutation in the receptor-binding domain of the spike protein have spread rapidly in the United Kingdom. The 501Y lineage without amino acid deletion Delta 69/Delta 70 was estimated to be 10% more transmissible than the 501N lineage, while the 501Y lineage with amino acid deletion Delta 69/Delta 70 was estimated to be 75% more transmissible than the 501N lineage.

EUROSURVEILLANCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Lewis F. Buss et al.

Summary: Research indicates that the attack rate of COVID-19 in Manaus, the capital of Amazonas state in northern Brazil, reached 66% in June 2020, rising to 76% by October, higher than the estimated attack rate of 29% in Sao Paulo, southeastern Brazil, during the same period.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Stabilizing the closed SARS-CoV-2 spike trimer

Jarek Juraszek et al.

Summary: Researchers have successfully created a stable variant of the SARS-CoV-2 S protein through structure-based design, with increased expression and correct folding predominantly in a closed prefusion conformation. This contributes to supporting vaccine development efforts.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Virology

Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink

Matthijs R. A. Welkers et al.

Summary: Recent studies have shown multiple transmission events of SARS-CoV-2 between humans and minks on farms, resulting in viral mutations. These mutations may affect the interaction between the virus and minks as well as humans, highlighting the importance of continued monitoring and attention to this issue.

VIRUS EVOLUTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Piyada Supasa et al.

Summary: Research on the UK-dominant variant B.1.1.7 shows that it is harder to neutralize than the parental virus, but widespread escape from antibodies or monoclonal antibodies has not been observed yet.

CELL (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Xiaoying Shen et al.

Summary: Current COVID-19 vaccines target the ancestral SARS-CoV-2 spike, but the emerging B.1.1.7 variant with multiple spike mutations may impact some antibody therapies while posing no major concerns for vaccine efficacy or increased risk of reinfection.

CELL HOST & MICROBE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization

Rafael Bayarri-Olmos et al.

Summary: A new variant discovered in minks has shown enhanced transmission capacity but does not affect immunity in previously infected individuals or vaccine models. The rise in frequency of this variant in mink farms may be due to a fitness advantage conferred by receptor adaptation rather than evading immune responses.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Ester C. Sabino et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 spike D614G change enhances replication and transmission

Bin Zhou et al.

Summary: Research has shown that the D614G substitution in the spike protein of SARS-CoV-2 leads to increased binding and replication potential in humans, as well as significantly higher replication and transmissibility in different animal models, providing an explanation for the global prevalence of this variant in the COVID-19 pandemic.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2

Francis K. Yoshimoto

Summary: The global pandemic in 2020 was caused by the virus SARS CoV-2, with discussions on the chemistry of its various nonstructural proteins and the significance of variant strains. The emerging strains like D614G, 501Y.V1, and 501Y.V2 show structural changes that increase infectivity, emphasizing the need for continued efforts in researching and understanding this rapidly evolving virus.

PROTEIN JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa

Meredith Wadman

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

Kui K. Chan et al.

Summary: The study suggests that engineered decoy receptors can tightly bind to the S protein of SARS-related viruses, and are expected to be effective against future coronavirus outbreaks.

SCIENCE ADVANCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Matthew McCallum et al.

Summary: The study identifies 41 human monoclonal antibodies that recognize the N-terminal domain of the SARS-CoV-2 spike protein and exhibit strong neutralizing activity. These antibodies inhibit cell-to-cell fusion, activate effector functions, and protect animals from virus challenge, highlighting the importance of NTD-specific neutralizing antibodies for protective immunity and vaccine development. Several SARS-CoV-2 variants with mutations in the NTD supersite suggest ongoing selective pressure on the virus.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann et al.

Summary: The emerging SARS-CoV-2 variants may exhibit resistance to existing neutralizing antibodies and treatments, which could have significant implications for pandemic containment efforts.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Antibody evasion by the P.1 strain of SARS-CoV-2

Wanwisa Dejnirattisai et al.

Summary: Ending the SARS-CoV-2 pandemic requires global vaccination. New virus strains with mutations impact antibody responses, but some variants are less resistant than others. A monoclonal antibody can neutralize different variants and partially restore neutralization potency for other public antibodies.

CELL (2021)

Add to Collection

Article Microbiology

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Pengfei Wang et al.

Summary: The emerging Brazilian variant P.1 shows increased resistance to antibody neutralization, posing a threat to current antibody therapies, but has less impact on the effectiveness of protective vaccines.

CELL HOST & MICROBE (2021)

Add to Collection

Article Environmental Sciences

Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing

Jack Schijven et al.

Summary: This study assessed the risk of illness due to airborne SARS-CoV-2 particles from breathing, speaking, singing, coughing, and sneezing in indoor environments. The results showed that sneezing had the highest volume of expelled aerosols, while singing became the second highest risk scenario after 2 hours of exposure.

ENVIRONMENTAL HEALTH PERSPECTIVES (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary et al.

Summary: A post-hoc analysis was conducted on the efficacy of the ChAdOx1 nCoV-19 vaccine against the B.1.1.7 variant of SARS-CoV-2 in the UK. The vaccine showed reduced neutralisation activity against the B.1.1.7 variant in vitro, but still demonstrated efficacy against the B.1.1.7 variant of the virus.

LANCET (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity

Muthukumar Ramanathan et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants reveal features critical for replication in primary human cells

Marie O. Pohl et al.

Summary: This study characterized different SARS-CoV-2 isolates from major European clades during the early phase of the pandemic in 2020 and identified sequence features associated with distinct phenotypes, such as variations affecting replication in specific cell types. It highlights the importance of carefully monitoring newly emerging variants or potential variants of concern in SARS-CoV-2 stocks.

PLOS BIOLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Emma C. Wall et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Jianying Liu et al.

Summary: Serum samples from individuals vaccinated with the BNT162b2 vaccine can neutralize various SARS-CoV-2 variants, indicating mass immunization as a central strategy to end the global COVID-19 pandemic.

NATURE (2021)

Add to Collection

Article Immunology

Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada

Nancy Matic et al.

Summary: In Vancouver, British Columbia, Canada, a real-time reverse transcription PCR-based algorithm was used to screen all severe acute respiratory syndrome coronavirus 2-positive samples and identify variants of concern. A total of 77 samples with variants were rapidly identified, with majority being B.1.1.7 and 8.1.351 variants.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Letter Immunology

Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy

Fabrizio Maggi et al.

Summary: This case is an imported one where an asymptomatic traveler arrived in Italy and tested positive for the SARS-CoV-2 variant P.1 after traveling indirectly from Brazil, highlighting the risk of introducing SARS-CoV-2 variants through indirect flights and the importance of continued surveillance for SARS-CoV-2.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Bas B. Oude Munnink et al.

Summary: Animal experiments have shown that various animals can be infected by SARS-CoV-2, with evidence of animal-to-human transmission within mink farms. Investigation into mink farm outbreaks revealed that the virus was initially introduced by humans and has since evolved, causing transmission between mink farms. Despite enhanced biosecurity measures and culling, transmission occurred between farms in three large clusters with unknown modes of transmission, resulting in a high percentage of infections among mink farm residents and employees.

SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Immunology

RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak

Liangjun Chen et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors

Matthew Hackbart et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2

Youngchang Kim et al.

PROTEIN SCIENCE (2020)

Add to Collection

Article Cell Biology

Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2

Qi Peng et al.

CELL REPORTS (2020)

Add to Collection

Article Biology

SARS-CoV-2 (COVID-19) by the numbers

Yinon M. Bar-On et al.

ELIFE (2020)

Add to Collection

Article Medicine, General & Internal

Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site

Umesh Kalathiya et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

Tommy Tsan-Yuk Lam et al.

NATURE (2020)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020

Nadia Oreshkova et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Article Immunology

ACE2, Much More Than Just a Receptor for SARS-COV-2

Lobelia Samavati et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Ahmad Abu Turab Naqvi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

Sarah R. Leist et al.

CELL (2020)

Add to Collection

Article Virology

The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2

Natacha S. Ogando et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Review Immunology

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Andrew G. Harrison et al.

TRENDS IN IMMUNOLOGY (2020)

Add to Collection

Article Microbiology

From People to Panthera: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo

Denise McAloose et al.

MBIO (2020)

Add to Collection

Article Veterinary Sciences

SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic

Khan Sharun et al.

VETERINARY QUARTERLY (2020)

Add to Collection

Review Immunology

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Mei-Yue Wang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Letter Infectious Diseases

CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants

Intikhab Alam et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

Review Microbiology

Origin and evolution of pathogenic coronaviruses

Jie Cui et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Add to Collection

Article Pharmacology & Pharmacy

Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein

Jian Lei et al.

ANTIVIRAL RESEARCH (2018)

Add to Collection

Article Multidisciplinary Sciences

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

Robert N. Kirchdoerfer et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Microbiology

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2

Wenfei Song et al.

PLOS PATHOGENS (2018)

Add to Collection

Article Cell Biology

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Miao Gui et al.

CELL RESEARCH (2017)

Add to Collection

Article Multidisciplinary Sciences

Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion

Alexandra C. Walls et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection

Article Multidisciplinary Sciences

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer

Alexandra C. Walls et al.

NATURE (2016)

Add to Collection

Article Multidisciplinary Sciences

Pre-fusion structure of a human coronavirus spike protein

Robert N. Kirchdoerfer et al.

NATURE (2016)

Add to Collection

Article Multidisciplinary Sciences

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

Jung-Eun Park et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Article Multidisciplinary Sciences

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Jean Kaoru Millet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Article Microbiology

Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia

A. N. Alagaili et al.

mBio (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Autoprocessing mechanism of severe acute respiratory syndrome coronavirus3C-like protease (SARS-CoV 3CLpro) from its polyproteins

Tomonari Muramatsu et al.

FEBS JOURNAL (2013)

Add to Collection

Article Multidisciplinary Sciences

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

V. Stalin Raj et al.

NATURE (2013)

Add to Collection

Article Medicine, General & Internal

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Ali Moh Zaki et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Biochemical Research Methods

Structure of the C-terminal domain of nsp4 from feline coronavirus

Ioannis Manolaridis et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)

Add to Collection

Article Multidisciplinary Sciences

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Sandrine Belouzard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Add to Collection

Article Virology

Novel beta-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus

Marcius S. Almeida et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Virology

Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs

Jeremiah S. Joseph et al.

JOURNAL OF VIROLOGY (2006)

Add to Collection

Article Biochemistry & Molecular Biology

Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer

YJ Zhai et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)

Add to Collection

Article Multidisciplinary Sciences

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

F Li et al.

SCIENCE (2005)

Add to Collection

Article Multidisciplinary Sciences

The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world

MP Egloff et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

Article Virology

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity

BH Harcourt et al.

JOURNAL OF VIROLOGY (2004)

Add to Collection

Article Medicine, General & Internal

A novel coronavirus associated with severe acute respiratory syndrome

TG Ksiazek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.